
Results
2
2 companies
MedinCell
Market Cap: €877.7m
Engages in the research and development of biodegradable polymer-based processes for the controlled and prolonged delivery of active pharmaceutical ingredients into the human body and animals in France.
MEDCL
€24.44
7D
-2.6%
1Y
54.0%
DBV Technologies
Market Cap: €723.2m
A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.
DBV
€2.44
7D
5.6%
1Y
41.6%